Barbara Cebula‐Obrzut

1.4k total citations
74 papers, 1.1k citations indexed

About

Barbara Cebula‐Obrzut is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Barbara Cebula‐Obrzut has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 30 papers in Genetics and 20 papers in Oncology. Recurrent topics in Barbara Cebula‐Obrzut's work include Chronic Lymphocytic Leukemia Research (26 papers), Cell death mechanisms and regulation (14 papers) and Acute Myeloid Leukemia Research (11 papers). Barbara Cebula‐Obrzut is often cited by papers focused on Chronic Lymphocytic Leukemia Research (26 papers), Cell death mechanisms and regulation (14 papers) and Acute Myeloid Leukemia Research (11 papers). Barbara Cebula‐Obrzut collaborates with scholars based in Poland, United States and Austria. Barbara Cebula‐Obrzut's co-authors include Piotr Smolewski, Tadeusz Robak, Olga Grzybowska‐Izydorczyk, Agnieszka Pluta, Agnieszka Wierzbowska, Anna Szmigielska‐Kapłon, Agata Wrzesień‐Kuś, Agnieszka Kaufman‐Szymczyk, Krzysztof Jamroziak and Krystyna Fabianowska‐Majewska and has published in prestigious journals such as Blood, Cancer and International Journal of Molecular Sciences.

In The Last Decade

Barbara Cebula‐Obrzut

70 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Cebula‐Obrzut Poland 21 527 342 309 304 267 74 1.1k
Juraj Bodo United States 17 665 1.3× 429 1.3× 240 0.8× 354 1.2× 252 0.9× 48 1.3k
Kourosh Lotfi Sweden 18 400 0.8× 283 0.8× 108 0.3× 264 0.9× 383 1.4× 54 968
Monica Pallis United Kingdom 23 674 1.3× 168 0.5× 155 0.5× 509 1.7× 590 2.2× 61 1.3k
Barbara Peter Austria 21 417 0.8× 141 0.4× 392 1.3× 119 0.4× 135 0.5× 48 1.1k
Karen Dunn United Kingdom 13 801 1.5× 261 0.8× 207 0.7× 180 0.6× 510 1.9× 29 1.4k
Tetsuo Nishiura Japan 22 640 1.2× 134 0.4× 384 1.2× 165 0.5× 341 1.3× 44 1.2k
Mingjie Li United States 19 583 1.1× 109 0.3× 276 0.9× 624 2.1× 682 2.6× 94 1.4k
Guy B. Faguet United States 15 201 0.4× 312 0.9× 287 0.9× 145 0.5× 105 0.4× 50 845
Zhihong Fang China 19 851 1.6× 107 0.3× 486 1.6× 424 1.4× 468 1.8× 72 1.5k
Miki Nishimura Japan 18 422 0.8× 70 0.2× 122 0.4× 264 0.9× 463 1.7× 49 1.1k

Countries citing papers authored by Barbara Cebula‐Obrzut

Since Specialization
Citations

This map shows the geographic impact of Barbara Cebula‐Obrzut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Cebula‐Obrzut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Cebula‐Obrzut more than expected).

Fields of papers citing papers by Barbara Cebula‐Obrzut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Cebula‐Obrzut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Cebula‐Obrzut. The network helps show where Barbara Cebula‐Obrzut may publish in the future.

Co-authorship network of co-authors of Barbara Cebula‐Obrzut

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Cebula‐Obrzut. A scholar is included among the top collaborators of Barbara Cebula‐Obrzut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Cebula‐Obrzut. Barbara Cebula‐Obrzut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smolewski, Piotr, et al.. (2023). Cytotoxic Activity of Melatonin Alone and in Combination with Doxorubicin and/or Dexamethasone on Diffuse Large B-Cell Lymphoma Cells in In Vitro Conditions. Journal of Personalized Medicine. 13(9). 1314–1314. 2 indexed citations
2.
Robak, Tadeusz, et al.. (2023). Atypical Chronic Lymphocytic Leukemia—The Current Status. Cancers. 15(18). 4427–4427. 11 indexed citations
3.
Witkowska, Magdalena, Agata Majchrzak, Barbara Cebula‐Obrzut, et al.. (2016). Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies. Molecules. 21(8). 995–995. 6 indexed citations
4.
Lubecka, Katarzyna, Agnieszka Kaufman‐Szymczyk, Barbara Stefañska, et al.. (2015). Sulforaphane Alone and in Combination with Clofarabine Epigenetically Regulates the Expression of DNA Methylation-Silenced Tumour Suppressor Genes in Human Breast Cancer Cells. Lifestyle Genomics. 8(2). 91–101. 56 indexed citations
5.
Kołacińska, Agnieszka, Barbara Cebula‐Obrzut, Justyna Chałubińska‐Fendler, et al.. (2015). Immune checkpoints: Cytotoxic T-lymphocyte antigen 4 and programmed cell death protein 1 in breast cancer surgery. Oncology Letters. 10(2). 1079–1086. 12 indexed citations
6.
Szymańska, J., Piotr Smolewski, Agata Majchrzak, et al.. (2015). Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination with Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines. Advances in Clinical and Experimental Medicine. 24(2). 195–202. 6 indexed citations
7.
Lubecka, Katarzyna, Agnieszka Kaufman‐Szymczyk, Barbara Stefañska, et al.. (2013). Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells. European Journal of Pharmacology. 723. 276–287. 24 indexed citations
8.
Błoński, Jerzy Z., Barbara Cebula‐Obrzut, Ewa Wawrzyniak, et al.. (2013). In vivo and ex vivo responses of CLL cells to purine analogs combined with alkylating agent. Pharmacological Reports. 65(2). 460–475. 3 indexed citations
9.
Hikisz, Paweł, Barbara Cebula‐Obrzut, Jerzy Z. Błoński, et al.. (2013). Promising anti-leukemic activity of atorvastatin. Oncology Reports. 29(5). 2065–2071. 6 indexed citations
10.
Majchrzak, Agata, et al.. (2013). Mechanisms of action of the anti-VEGF monoclonal antibody bevacizumab on chronic lymphocytic leukemia cells. Postępy Higieny i Medycyny Doświadczalnej. 67. 107–118. 13 indexed citations
11.
Lech‐Marańda, Ewa, Olga Grzybowska‐Izydorczyk, Krystyna Wyka, et al.. (2012). Serum Tumor Necrosis Factor-α and Interleukin-10 Levels as Markers to Predict Outcome of Patients with Chronic Lymphocytic Leukemia in Different Risk Groups Defined by the IGHV Mutation Status. Archivum Immunologiae et Therapiae Experimentalis. 60(6). 477–486. 15 indexed citations
12.
Błoński, Jerzy Z., Barbara Cebula‐Obrzut, Piotr Smolewski, et al.. (2011). Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment. Medical Oncology. 29(3). 2111–2126. 2 indexed citations
13.
Pluta, Agnieszka, Agata Wrzesień‐Kuś, Barbara Cebula‐Obrzut, et al.. (2010). Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients. Leukemia Research. 34(10). 1308–1313. 22 indexed citations
14.
Narbutt, Joanna, Barbara Cebula‐Obrzut, Aleksandra Lesiak, et al.. (2009). The Effect of Repeated Exposures to Low-Dose UV Radiation on the Apoptosis of Peripheral Blood Mononuclear Cells. Archives of Dermatology. 145(2). 133–8. 8 indexed citations
15.
Smolewska, Elżbieta, et al.. (2008). Relationship between impaired apoptosis of lymphocytes and distribution of dendritic cells in peripheral blood and synovial fluid of children with juvenile idiopathic arthritis. Archivum Immunologiae et Therapiae Experimentalis. 56(4). 283–289. 7 indexed citations
16.
Robak, Tadeusz, Piotr Smolewski, Barbara Cebula‐Obrzut, Olga Grzybowska‐Izydorczyk, & Jerzy Z. Błoński. (2007). Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia. European Journal Of Haematology. 79(2). 107–113. 40 indexed citations
17.
Wierzbowska, Agnieszka, Tadeusz Robak, Agnieszka Pluta, et al.. (2007). Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients. Annals of Hematology. 87(2). 97–106. 17 indexed citations
18.
19.
Jamroziak, Krzysztof, Ewa Balcerczak, Barbara Cebula‐Obrzut, et al.. (2006). No Influence of 3435C>T ABCB1 (MDR1) Gene Polymorphism on Risk of Adult Acute Myeloid Leukemia and P-glycoprotein Expression in Blast Cells. Therapeutic Drug Monitoring. 28(5). 707–711. 23 indexed citations
20.
Wierzbowska, Agnieszka, Tadeusz Robak, Agata Wrzesień‐Kuś, et al.. (2005). Circulating endothelial cells in patients with acute myeloid leukemia. European Journal Of Haematology. 75(6). 492–497. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juraj Bodo Breakdown of academic impact, for papers by Kourosh Lotfi Breakdown of academic impact, for papers by Monica Pallis Breakdown of academic impact, for papers by Barbara Peter Breakdown of academic impact, for papers by Karen Dunn Breakdown of academic impact, for papers by Tetsuo Nishiura Breakdown of academic impact, for papers by Mingjie Li Breakdown of academic impact, for papers by Guy B. Faguet Breakdown of academic impact, for papers by Zhihong Fang Breakdown of academic impact, for papers by Miki Nishimura
Rankless by CCL
2026